12:25 PM
 | 
Feb 23, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Ra raises $50.4M in follow-on

Complement-mediated disease company Ra Pharmaceuticals Inc. (NASDAQ:RARX) raised $50.4 million on Feb. 14 through the sale of...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >